Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 06, 2025 11:39 ET | Source: BPGbio

BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer

Company strengthens its late-stage trials with enhanced clinical and commercial leadership for its BPM31510 programs
August 27, 2025 16:52 ET | Source: Countdown For A Cure

Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research

ATLANTA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Countdown For A Cure, a foundation dedicated to accelerating mitochondrial research and medicine, today announced a $350,000 grant to Minovia Therapeutics...
April 25, 2025 07:00 ET | Source: BPGbio

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BPGbio highlights groundbreaking data on BPM31510 illustrating it's therapeutic impact as a potential treatment for primary CoQ10 deficiency.
April 23, 2025 07:00 ET | Source: BPGbio

BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025

BPGbio presents new research on the power of mitochondrial medicine and protein homeostasis technologies to address aggressive cancers at AACR.
September 09, 2014 03:00 ET | Source: OnCore Biopharma, Inc.

OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection

OnCore Secures Exclusive Worldwide Rights to NVP018 NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...